Balyasny Asset Management LLC Lannett CO Inc Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$6.43 - $9.86 $222,928 - $341,846	-34,670 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.36 - $10.05 $220,501 - $348,433	34,670 New	34,670 $241,000
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $139,474 - $425,763	-29,363 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.45 $390,527 - $512,384	29,363 New	29,363 $399,000
Q1 2018 May 15, 2018	SELL	$14.7 - $24.95 $514,500 - $873,250	-35,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.1 - $19.25 $528,500 - $673,750	35,000	35,000 $646,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.